Correlation Between Coty and Calliditas Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coty and Calliditas Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coty and Calliditas Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coty Inc and Calliditas Therapeutics, you can compare the effects of market volatilities on Coty and Calliditas Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coty with a short position of Calliditas Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coty and Calliditas Therapeutics.

Diversification Opportunities for Coty and Calliditas Therapeutics

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Coty and Calliditas is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Coty Inc and Calliditas Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calliditas Therapeutics and Coty is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coty Inc are associated (or correlated) with Calliditas Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calliditas Therapeutics has no effect on the direction of Coty i.e., Coty and Calliditas Therapeutics go up and down completely randomly.

Pair Corralation between Coty and Calliditas Therapeutics

Given the investment horizon of 90 days Coty Inc is expected to generate 0.47 times more return on investment than Calliditas Therapeutics. However, Coty Inc is 2.14 times less risky than Calliditas Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Calliditas Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  1,103  in Coty Inc on February 5, 2024 and sell it today you would earn a total of  57.00  from holding Coty Inc or generate 5.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Coty Inc  vs.  Calliditas Therapeutics

 Performance 
       Timeline  
Coty Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coty Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Coty is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Calliditas Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Calliditas Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Calliditas Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Coty and Calliditas Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coty and Calliditas Therapeutics

The main advantage of trading using opposite Coty and Calliditas Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coty position performs unexpectedly, Calliditas Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calliditas Therapeutics will offset losses from the drop in Calliditas Therapeutics' long position.
The idea behind Coty Inc and Calliditas Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stocks Directory
Find actively traded stocks across global markets